Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 20


Establishing an Advanced Practice Nursing Clinic in the Cancer Setting.

Blakely K, Cope DG.

Semin Oncol Nurs. 2015 Nov;31(4):282-9. doi: 10.1016/j.soncn.2015.08.004. Epub 2015 Aug 13.


FGF23: mediator of poor prognosis in a sizeable subgroup of patients with castration-resistant prostate cancer presenting with severe hypophosphatemia?

Lee EK, Martinez MC, Blakely K, Santos KD, Hoang VC, Chow A, Emmenegger U.

Med Hypotheses. 2014 Oct;83(4):482-7. doi: 10.1016/j.mehy.2014.08.005. Epub 2014 Aug 11.


Context-dependent role of ATG4B as target for autophagy inhibition in prostate cancer therapy.

Tran E, Chow A, Goda T, Wong A, Blakely K, Rocha M, Taeb S, Hoang VC, Liu SK, Emmenegger U.

Biochem Biophys Res Commun. 2013 Nov 29;441(4):726-31. doi: 10.1016/j.bbrc.2013.10.117. Epub 2013 Oct 30.


A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines.

Vojvodic M, Hansford LM, Morozova O, Blakely KM, Taylor P, Fathers KE, Moffat J, Marra M, Smith KM, Moran MF, Kaplan DR.

Curr Drug Discov Technol. 2013 Dec;10(4):283-304.


CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope.

Mak AB, Blakely KM, Williams RA, Penttilä PA, Shukalyuk AI, Osman KT, Kasimer D, Ketela T, Moffat J.

J Biol Chem. 2011 Nov 25;286(47):41046-56. doi: 10.1074/jbc.M111.261545. Epub 2011 Sep 21.


Pooled lentiviral shRNA screening for functional genomics in mammalian cells.

Blakely K, Ketela T, Moffat J.

Methods Mol Biol. 2011;781:161-82. doi: 10.1007/978-1-61779-276-2_9.


Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole.

Spitzer M, Griffiths E, Blakely KM, Wildenhain J, Ejim L, Rossi L, De Pascale G, Curak J, Brown E, Tyers M, Wright GD.

Mol Syst Biol. 2011 Jun 21;7:499. doi: 10.1038/msb.2011.31.


A comprehensive platform for highly multiplexed mammalian functional genetic screens.

Ketela T, Heisler LE, Brown KR, Ammar R, Kasimer D, Surendra A, Ericson E, Blakely K, Karamboulas D, Smith AM, Durbic T, Arnoldo A, Cheung-Ong K, Koh JL, Gopal S, Cowley GS, Yang X, Grenier JK, Giaever G, Root DE, Moffat J, Nislow C.

BMC Genomics. 2011 May 6;12:213. doi: 10.1186/1471-2164-12-213.


Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens.

Smith KM, Datti A, Fujitani M, Grinshtein N, Zhang L, Morozova O, Blakely KM, Rotenberg SA, Hansford LM, Miller FD, Yeger H, Irwin MS, Moffat J, Marra MA, Baruchel S, Wrana JL, Kaplan DR.

EMBO Mol Med. 2010 Sep;2(9):371-84. doi: 10.1002/emmm.201000093.


System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma.

Morozova O, Vojvodic M, Grinshtein N, Hansford LM, Blakely KM, Maslova A, Hirst M, Cezard T, Morin RD, Moore R, Smith KM, Miller F, Taylor P, Thiessen N, Varhol R, Zhao Y, Jones S, Moffat J, Kislinger T, Moran MF, Kaplan DR, Marra MA.

Clin Cancer Res. 2010 Sep 15;16(18):4572-82. doi: 10.1158/1078-0432.CCR-10-0627. Epub 2010 Jul 22. Erratum in: Clin Cancer Res. 2010 Dec 1;16(23):5914.


A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency.

Mak AB, Ni Z, Hewel JA, Chen GI, Zhong G, Karamboulas K, Blakely K, Smiley S, Marcon E, Roudeva D, Li J, Olsen JB, Wan C, Punna T, Isserlin R, Chetyrkin S, Gingras AC, Emili A, Greenblatt J, Moffat J.

Mol Cell Proteomics. 2010 May;9(5):811-23. doi: 10.1074/mcp.M000002-MCP201. Epub 2010 Mar 19.


Elevated mPer1 gene expression in tumor stroma imaged through bioluminescence.

Geusz ME, Blakely KT, Hiler DJ, Jamasbi RJ.

Int J Cancer. 2010 Feb 1;126(3):620-30. doi: 10.1002/ijc.24788.


Structure and function of sedoheptulose-7-phosphate isomerase, a critical enzyme for lipopolysaccharide biosynthesis and a target for antibiotic adjuvants.

Taylor PL, Blakely KM, de Leon GP, Walker JR, McArthur F, Evdokimova E, Zhang K, Valvano MA, Wright GD, Junop MS.

J Biol Chem. 2008 Feb 1;283(5):2835-45. Epub 2007 Dec 3.


Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.

O'Dell JR, Elliott JR, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, Blakely KM, Hausch R, Leff RD.

Arthritis Rheum. 2006 Feb;54(2):621-7.


Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.

O'Dell JR, Petersen K, Leff R, Palmer W, Schned E, Blakely K, Haire C, Fernandez A.

J Rheumatol. 2006 Feb;33(2):213-8. Epub 2005 Dec 15.


Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.

O'Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, Fernandez A, Blakely K, Wees S, Stoner J, Hadley S, Felt J, Palmer W, Waytz P, Churchill M, Klassen L, Moore G.

Arthritis Rheum. 2002 May;46(5):1164-70.


Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine.

O'Dell JR, Blakely KW, Mallek JA, Eckhoff PJ, Leff RD, Wees SJ, Sems KM, Fernandez AM, Palmer WR, Klassen LW, Paulsen GA, Haire CE, Moore GF.

Arthritis Rheum. 2001 Oct;44(10):2235-41.


Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial.

O'Dell JR, Paulsen G, Haire CE, Blakely K, Palmer W, Wees S, Eckhoff PJ, Klassen LW, Churchill M, Doud D, Weaver A, Moore GF.

Arthritis Rheum. 1999 Aug;42(8):1691-5.


Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.

O'Dell JR, Haire CE, Palmer W, Drymalski W, Wees S, Blakely K, Churchill M, Eckhoff PJ, Weaver A, Doud D, Erikson N, Dietz F, Olson R, Maloley P, Klassen LW, Moore GF.

Arthritis Rheum. 1997 May;40(5):842-8.


The quest for health.


RN. 1948 Oct;12(1):42-4. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk